Stoke Therapeutics: , Including Exhibits 99.1 And 99.2, Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Incorporated By Reference Into Any Other Filing Under The Exchange Act Or The Securities Act Of 1933, As Amended, Except As Expressly Set Forth By Specific Reference In Such A Filing, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Stoke Therapeutics, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***